Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial
- 30 July 2021
- journal article
- research article
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (5) , e15075
Abstract
Introduction Psoriasis is a common chronic skin condition, which is an immune-related hyperproliferative disorder. Among the different treatments for psoriasis, statins have been found to reduce the severity of the disease. Accordingly, fluvastatin and simvastatin are known to have anti-inflammatory effects by inhibiting inflammatory cytokines and lymphocyte function. Narrowband UVB (NB-UVB) is known as an effective and safe modality for psoriasis treatment. In this double-blind, randomized controlled trial, we investigated the efficacy and safety of adding simvastatin to NB-UVB phototherapy in patients with psoriasis. Method Forty-eight patients with psoriasis undergoing NB-UVB phototherapy were randomly divided into placebo groups; one received oral simvastatin, and the other received a placebo for 12 weeks. Psoriasis severity was assessed with the Psoriasis Area and Severity Index (PASI) and Dermatology Life and Quality Index (DLQI). Results Both groups showed a significant decline in PASI score after 6 and 12 weeks compared to the baseline. The differences in reducing PASI score and DLQI between the two groups were not significant neither at week sixth nor 12th. Also, DLQI decreased significantly in the placebo group at week 12th. Conclusion In contrast with previous studies, we did not find any additional effects for oral simvastatin5 in treating psoriasis with NB-UVB. Also, an insignificant difference in the improvement of quality of life between both groups was ascertained.Keywords
This publication has 25 references indexed in Scilit:
- Rational for statin use in psoriatic patientsArchives of Dermatological Research, 2013
- The association between psoriasis and dyslipidaemia: a systematic reviewBritish Journal of Dermatology, 2013
- Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatmentExperimental Dermatology, 2011
- Psoriasis: Targeting Therapy Towards the Inflammatory CascadeAmerican Journal of Clinical Dermatology, 2010
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2010
- European S3‐Guidelines on the systemic treatment of psoriasis vulgarisJournal of the European Academy of Dermatology and Venereology, 2009
- Efficacy of simvastatin in plaque psoriasis: A pilot studyJournal of the American Academy of Dermatology, 2007
- Statin therapy and autoimmune disease: from protein prenylation to immunomodulationNature Reviews Immunology, 2006
- Statins: novel additions to the dermatologic arsenal?Experimental Dermatology, 2004
- Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductaseAmerican Heart Journal, 2002